NetScientific News

RNS Announcements

NetScientific plc (“NetScientific” or the “Company”) ProAxsis Limited appoints DiaPharma as distributor to key North America region London, UK – 19 November 2020 – NetScientific plc (AIM: NSCI), the …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine PDS0203 prioritized for clinical development by PDS Biotech and Farmacore …

NetScientific plc (“NetScientific” or the “Company”)   PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck VERSATILE-002 …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care Chemoradiotherapy in Advanced Cervical Cancer London, …

NetScientific plc (“NetScientific” or the “Company”)   NetScientific plc (“NetScientific” or the “Company”) NetScientific acquires 100% control of portfolio company ProAxsis Limited London, UK – 16 October 2020 – NetScientific plc …

NetScientific plc (“NetScientific” or the “Company”)   Grant of Options to Director London, UK – 25 September 2020 – NetScientific plc (AIM:NSCI) (the “Company”), the life sciences and technology Group, announces …

NetScientific plc (“NetScientific” or the “Company” or the “Group”) Interim Results for the six months ended 30 June 2020   London, UK – 24 September 2020: NetScientific Plc …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

NetScientific plc (“NetScientific” or the “Company”)   Result of General Meeting NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, is pleased to announce at its General Meeting held …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

NetScientific plc (“NetScientific” or the “Company”)    Issue of Equity NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that to ensure that the number of Interim …

Subscribe to News via Email

Enter your email address to subscribe to Netscientic News and receive notifications by email.

Media

Francois Martelet, chief executive of NetScientific PLC (LON:NSCI) caught up with Proactive’s Andrew Scott to update on developments within the IP commercialisation specialist’s portfolio. Francois Martelet, chief executive …

London, UK – 05 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, today announces that its management team will attend the following key investor …

  London, UK – 08 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group announces that Francois Martelet, Chief Executive Officer, will be …

François Martelet M.D Netscientific Chief Executive Officer speaks about Netscientific transatlantic healthcare technology group. NetScientific is a transatlantic healthcare IP commercialisation group. We fund and develop companies …

NetScientific plc (LON:NSCI) chief executive and chairman Francois Martelet hailed recent news from portfolio company Vortex Biosciences as a “very important” milestone. Vortex has been awarded a …

Biomedical and healthcare incubator NetScientific PLC (LON:NSCI) had a busy first half to the year, focusing on “execution, execution, execution”, according to chief executive officer François Martelet. …

NetScientific Portfolio News

News_1 - NetScientific